Nintedanib in the treatment of interstitial lung disease associated with systemic sclerosis: A justified hope?

被引：0
|
作者：
Hachulla, E. [1 ]
机构：
[1] Hop Claude Huriez, Ctr Reference Malad Autoimmunes & Autoinflammatoi, Serv Med Interne & Immunol Clin, F-59037 Lille, France
来源：
REVUE DE MEDECINE INTERNE | 2019年 / 40卷 / 12期
关键词：
Nintedanib; Systemic sclerosis; Interstitial lung disease; SCLERODERMA LUNG; CONTROLLED-TRIAL; PLACEBO; CYCLOPHOSPHAMIDE;
D O I：
10.1016/j.revmed.2019.08.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：775 / 777
页数：3
相关论文
共 50 条
  • [11] THE STUDY OF THE NINTEDANIB SAFETY PROFILE IN PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga A.
    Garzanova, Liudmila
    Ananyeva, Lidia
    Ovsyannikova, Olga
    Desinova, Oxana
    Starovoytova, Mayya
    CHEST, 2023, 164 (04) : 5483A - 5484A
  • [12] Molecular Evidences for Antifibrotic Potentials of Nintedanib in Interstitial Lung Disease Associated with Systemic Sclerosis
    Akter, T.
    Atanelishvili, I.
    Noguchi, A.
    Wollin, L.
    Silver, R. M.
    Bogatkevich, G. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [13] Treatment of systemic sclerosis-associated interstitial lung disease
    Prasse, A.
    Bonella, F.
    Mueller-Ladner, U.
    Witte, T.
    Hunzelmann, N.
    Distler, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 294 - 303
  • [14] Treatment for systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Lescoat, Alain
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
  • [15] Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease
    Atanelishvili, I.
    Akter, T.
    Noguchi, A.
    Vuyiv, O.
    Wollin, L.
    Silver, R. M.
    Bogatkevich, G. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (04) : S115 - S124
  • [16] Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON
    Allanore, Yannick
    Vonk, Madelon C.
    Distler, Oliver
    Azuma, Arata
    Mayes, Maureen D.
    Gahlemann, Martina
    James, Alexandra
    Kohlbrenner, Veronika
    Alves, Margarida
    Khanna, Dinesh
    Highland, Kristin B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12) : 1722 - 1729
  • [17] Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States
    Bernstein, Elana
    VanBuren, John
    Assassi, Shervin
    Castelino, Flavia
    Chung, Lorinda
    Correia, Chase
    Evnin, Luke
    Frech, Tracy
    Startup, Emily
    Gordon, Jessica
    Hant, Faye
    Hummers, Laura
    Sandorfi, Nora
    Shah, Ami
    Shanmugam, Victoria
    Steen, Virginia
    Khanna, Dinesh
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 795 - 798
  • [18] Interstitial Lung Disease Associated with Systemic Sclerosis
    Mismetti, Valentine
    Si-Mohamed, Salim
    Cottin, Vincent
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) : 342 - 364
  • [19] Systemic Sclerosis Associated Interstitial Lung Disease
    Steen, Virginia
    Weir, Nargues
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2015, 11 (02) : 110 - 118
  • [20] Systemic sclerosis associated interstitial lung disease
    Xanthouli, P.
    Hermann, W.
    Hunzelmann, N.
    Kreuter, M.
    PNEUMOLOGE, 2018, 15 (06): : 383 - 395
12345